Average Co-Inventor Count = 7.14
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (17 from 3,699 patents)
2. Arvinas Operations, Inc. (9 from 58 patents)
3. Yale University (5 from 1,332 patents)
26 patents:
1. 12441708 - Cereblon ligands and bifunctional compounds comprising the same
2. 12264157 - Compounds and methods for the enhanced degradation of targeted proteins
3. 11986531 - Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
4. 11964945 - Compounds and methods for the targeted degradation of androgen receptor
5. 11512083 - Compounds and methods for the enhanced degradation of targeted proteins
6. 11427548 - Compounds and methods for the targeted degradation of androgen receptor
7. 11236051 - Compounds and methods for the targeted degradation of androgen receptor
8. 10994015 - EGFR proteolysis targeting chimeric molecules and associated methods of use
9. 10730870 - Compounds and methods for the enhanced degradation of targeted proteins
10. 10550125 - Prodrugs of imidazotriazine compounds as CK2 inhibitors
11. 9556178 - Imidazotriazinecarbonitriles useful as kinase inhibitors
12. 9273057 - Imidazotriazinecarbonitriles useful as kinase inhibitors
13. 8940736 - Imidazotriazinecarbonitriles useful as kinase inhibitors
14. 8815840 - Carbazole and carboline kinase inhibitors
15. 8592579 - Pyrrolotriazine kinase inhibitors